|
|
||||||||
Department of Medical Cell Biology, Uppsala University, SE-751 23 Uppsala, Sweden
The aim of the study was to evaluate whether
a selective increase in portal vein blood glucose concentration can
affect pancreatic islet blood flow. Anesthetized rats were infused (0.1 ml/min for 3 min) directly into the portal vein with saline, glucose,
or 3-O-methylglucose. The infused dose of glucose (1 mg · kg body wt
1 · min
1)
was chosen so that the systemic blood glucose concentration was
unaffected. Intraportal infusion of D-glucose increased
insulin release and islet blood flow; the osmotic control substance
3-O-methylglucose had no such effect. A bilateral vagotomy
performed 20 min before the infusions potentiated the islet blood flow
response and also induced an increase in whole pancreatic blood flow,
whereas the insulin response was abolished. Administration of atropine
to vagotomized animals did not change the blood flow responses to intraportal glucose infusions. When the vagotomy was combined with a
denervation of the hepatic artery, there was no stimulation of islet
blood flow or insulin release after intraportal glucose infusion. We
conclude that a selective increase in portal vein blood glucose
concentration may participate in the islet blood flow increase in
response to hyperglycemia. This effect is probably mediated via
periarterial nerves and not through the vagus nerve. Furthermore, this
blood flow increase can be dissociated from changes in insulin release.
pancreatic blood flow; hepatic glucoreceptors; denervation; vagus nerve
This article has been cited by other articles:
![]() |
M. Fukaya, A. Mizuno, H. Arai, K. Muto, T. Uebanso, K. Matsuo, H. Yamamoto, Y. Taketani, T. Doi, and E. Takeda Mechanism of rapid-phase insulin response to elevation of portal glucose concentration Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E515 - E522. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Moore, M. J. Burish, B. Farmer, D. W. Neal, C. Pan, and A. D. Cherrington Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E845 - E853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |